RxDoctor Payments Data

Marcin Karcz

Critical Care Medicine · Bronxville, NYNPI 1144484569

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 46.7% of the total. 2025 is the largest year on record at $16,245, more than ten times the $168 reported in 2021. Among critical care medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,467in general payments, 2019–2025

Across 435 payments — averaging $83.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$17K
  • Saluda Medical Americas, Inc.$11K
  • Boston Scientific$4K
  • Relievant Medsystems, Inc.$1K
  • Medtronic$629
  • Vertos Medical, Inc.$502
  • plus $2K from 7 others

What the payments were for

  • Consulting fees$8,85024%
  • Travel & lodging$7,78321%
  • Food & beverage$19,83554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,467 in reported general payments places this provider in the 95th percentile of 442 critical care medicine providers in New York.

See all critical care medicine providers in New York

Medicare billing

Part B allowed, 2024
$209,700
Medicare patients
339
Services billed
1,142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen674$10,764
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen293$7,622
Fentanyl58$5,528
Buprenorphine11$2,607
Gabapentin115$1,646
Oxycodone Hcl62$1,474
Acetaminophen-CodeineAcetaminophen With Codeine44$1,325
Cephalexin206$1,079
Morphine Sulfate ErMorphine Sulfate41$724
Morphine Sulfate28$634
Tizanidine Hcl49$583
Cyclobenzaprine Hcl30$329
Pregabalin35$328
Methadone Hcl24$320
Tramadol Hcl30$175

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Bronxville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →